Publication: TLR4 Asp299Gly and Yhr399ile and TLR2 intron 2 microsatellite gene polymorphism in patients with acute biliary pancreatitis: does it cause the disease?
Loading...
Program
KU-Authors
Organization Authors
Co-Authors
Anılır, Ender
Özen, Filiz
Özemir, İbrahim Ali
Yıldırım, İbrahim Halil
Date
Language
Type
Embargo Status
N/A
Journal Title
Journal ISSN
Volume Title
Alternative Title
Abstract
Objectives: There has been coverage of Toll-like receptor 4 and Toll-like receptor 2 gene polymorphisms in inflammatory episodes in a number of studies. In view of the inflammatory nature of acute pancreatitis, we aimed to determine the predictive value of mutations in Asp299Gly and Thr399Ile of the Toll-like receptor 4 gene, and the intron 2 microsatellite polymorphism of the Toll-like receptor 2 gene on the occurrence of acute biliary pancreatitis. Material and Methods: The study included 86 patients for the Toll-like receptor 4 Thr399Ile polymorphism, 100 patients for the Toll-like receptor 4 Asp299Gly polymorphism with acute biliary pancreatitis, and 101 healthy volunteers. At the same time, 93 patients and 92 healthy volunteers were included in the study to research the Toll-like receptor 2 intron 2 microsatellite polymorphism. Genotypes were determined using the restriction fragment length polymorphism analysis of PCR products and by an allele-specific PCR. Results: The Toll-like receptor 4 Thr399Ile homozygotes mutant variants (p=0.005) and Toll-like receptor 2 MM genotype (p<0.001) were detected with a significantly higher frequency in patients with acute biliary pancreatitis than in the healthy blood donors. Conclusion: The Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms and the Toll-like receptor 2 intron 2 microsatellite polymorphism are statistically associated with ABP.
Source
Publisher
Aves
Subject
Citation
item.page.haspartof
Source
Turkish Journal of Surgery
item.page.ispartofseries
item.page.edition
DOI
10.5152/turkjsurg.2017.3828
item.page.datauri
item.page.link
Rights
N/A
Copyrights Note
Rights and licensing
N/A
